Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12610000840088Phase 3Not yet recruiting
Phase 3, double-blind trial of pilocarpine in xerostomia (2 arms), sponsored by The University of Queensland. Primary endpoint: Symptomatic improvement measured by mean numerical rating scores for average dry mouth. Planned start Nov 2010; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12610000840088.